Policies and procedures

Procedure M-13.4 Clozaril® Prescribing and Dispensing Procedures

R24 Unnecessary Drugs Skilled Nursing Facility

Key Points:

• Due to risk of agranulocytosis associated with Clozaril (clozapine) therapy, ALL patients receiving clozapine therapy must be monitored and registered with the manufacturer's specific surveillance program
• Pharmacist verifying order is responsible for ensuring patient is elibible and registered with TCPR before dispensing clozapine
  • Teva Clozapine Patient Registry (TCPR) contact information:
    • Phone: 1-844-267-8678
    • Fax: 1-800-507-8339
    • Email: Clozapine.Registry@TevaUSA.com
    • http://www.clozapineregistry.com
  • Clozapine ODT Registry
    • Phone: 1-877-507-2256
• Pharmacist must document "eligibility code/patient ID" from TCPR in patient's chart in EPIC
• Pharmacist may add patient to The Methodist Hospital's TCPR patient list

Consults, protocols, and therapeutic interchanges

Additional information

• Micromedex
• UpToDate
• Lexicomp